Atlas Trials

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

Clinical trial NCT07351786 · RECRUITING

Trial details

NCT number
NCT07351786
Sponsor
Sara A Belal
Status
RECRUITING
Study type
OBSERVATIONAL
Diabetes (DM)Retinopathy, DiabeticDiabetic Retinopathy (DR)Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus
Start date
2025-08-01
Primary completion
2026-08-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.